organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 3123 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2019 | 22 |
Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease |
|
| | | |
The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments |
|
| | | |
Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer’s disease-like pathologies |
|
| | | |
Energy and the Alzheimer brain |
|
| | | |
Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer’s Disease |
|
| | | |
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism |
|
| | | |
The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development |
|
| | | |
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies |
|
| | | |
Digital trail making test-black and white: Normal vs MCI |
|
| | | |
Validation of SATURN, a free, electronic, self-administered cognitive screening test |
|
| | | |
A selective review of the ability for variants of the Trail Making Test to assess cognitive impairment |
|
| | | |
Sericin protects against acute sleep deprivation-induced memory impairment via enhancement of hippocampal synaptic protein levels and inhibition of oxidative stress and neuroinflammation in mice |
|
| | | |
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease |
|
| | | |
Deconstructing the effects of concentration meditation practice on interference control: The roles of controlled attention and inflammatory activity |
|
| | | |
Diabesity Increases Inflammation and Oxidative Stress |
|
| | | |
Rosa canina L. methanolic extract prevents heat stress-induced memory dysfunction in rats |
|
| | | |
Oxidative stress and ageing in animals under thermal stress due to global warming: A perspective |
|
| | | |
Early Assessment of Extracorporeal Shock Wave Myocardial Revascularization (ESMR) |
|
| | | |
Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum |
|
| | | |
Pharmacogenomics of Alzheimer’s and Parkinson’s diseases |
|
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals